Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58

World J Gastroenterol. 2007 Mar 28;13(12):1841-6. doi: 10.3748/wjg.v13.i12.1841.

Abstract

Aim: To explore a specific diagnostic method for local recurrent rectal cancer.

Methods: Immunoscintigraphy with (99m)Tc-labeled anti-CEA monoclonal antibody (MoAb) CL-58 was performed for patients suspected of having a postoperative local recurrent rectal cancer and the findings were compared with the results of conventional imaging and pathology.

Results: A total of 36 patients with a suspected local recurrent rectal cancer underwent immunoscintigraphy with (99m)Tc-conjugated CL58. Local recurrence of rectal cancer was identified in 31 patients and established in 30 during operation, endoscopy and pathological examination. No local recurrence was found in 5 patients without specific accumulation of (99m)Tc during the follow-up. Immunoscintigraphy had a positive rate of 86.11%, a specificity of 83.33%, and a sensitivity of 100%.

Conclusion: Immunoscintigraphy has a highly specific and predictive value for detecting local recurrent rectal cancer, especially after abdominal perineal resection (APR).

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Antibodies, Monoclonal* / immunology
  • Carcinoembryonic Antigen / blood
  • Carcinoembryonic Antigen / immunology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnostic imaging*
  • Neoplasm Recurrence, Local / immunology
  • Positron-Emission Tomography
  • Predictive Value of Tests
  • Radioimmunodetection / methods*
  • Rectal Neoplasms / diagnostic imaging*
  • Rectal Neoplasms / immunology
  • Rectal Neoplasms / pathology
  • Sensitivity and Specificity
  • Technetium*
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • Antibodies, Monoclonal
  • Carcinoembryonic Antigen
  • Technetium